Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

EndyMed Medical and their Intensif Featured on The View
  • USA - English


News provided by

EndyMed Medical, Ltd.

Jul 09, 2015, 03:00 ET

Share this article

Share toX

Share this article

Share toX

The EndyMed Intensif
The EndyMed Intensif

Maximum results with no downtime as well as the highest level available of patient comfort delivered throughout.

Post this

New York (PRWEB) July 09, 2015 -- EndyMed Medical Ltd. and the FDA-approved Intensif microneedling handpiece were featured on The View, a popular American talk show, on Monday, June 29th 2015. The segment, entitled "Beauty Breakthroughs", featured esteemed New York dermatologist, Dr. Doris Day, who took The View moderator, Oscar-winner Whoopi Goldberg, and guest co-host, supermodel Molly Sims, through the latest and greatest in beauty technologies, treatments and products. While demonstrating a live procedure using EndyMed's Intensif microneedling handpiece, the hosts discussed the device's ability to address aesthetic skin issues like skin rejuvenation, acne scarring, stretch marks and discoloration on patients of all ages, races and skin types.

The segment highlighted EndyMed's proprietary 3DEEP® Radiofrequency technology, which is delivered through the non-insulated tapered gold needles of the Intensif handpiece, to boost the body's own natural production of collagen. Dr. Day and the co-hosts of The View also discussed that patients experience little to no discomfort while undergoing the procedure and no downtime. To further prove the effectiveness of the device and handpiece, several before and after patient photos from practices across the globe were included and shown throughout.

EndyMed's 3DEEP® Radiofrequency technology provides patients and providers in the U.S. with several unique advantages. The non-insulated, gold plated tapered needles of the Intensif deliver consistent energy to customized and targeted depths for maximum results with no downtime as well as the highest level available of patient comfort delivered throughout. Additionally, the multiple modality platform system also easily allows for combination treatments in one device, making EndyMed a complete tool for any aesthetic practice. In fact, the efficacy of EndyMed's proprietary technology was further proved and presented at the recent World Congress of Dermatology, where EndyMed was included in 4 poster presentations.

Dr. Doris Day is a board-certified dermatologist who specializes in laser, cosmetic and surgical dermatology in New York City. Dr. Day is affiliated with Lenox Hill Hospital in New York City and is a Clinical Associate Professor of Dermatology at the New York University Langone Medical Center. In addition to regularly lecturing on the art of techniques of soft tissue fillers, laser treatments and facial rejuvenation, Dr. Day is the author of two books – Forget the Facelift: Turn Back the Clock with Dr. Day's Revolutionary Four-Step Program for Ageless Skin and 100 Questions and Answers About Acne.

This segment is also featured on The View's official website, abc.go.com/shows/the-view, which has a unique visitor reach of 899,237. Below, you will find a link to the segment online:

Link to EndyMed Intensif Segment - The View

About EndyMed Intensif

The Intensif microneedling handpiece has been clinically proven to provide a revolutionary collagen remodeling solution for acne scars, pockmarks, deep wrinkles and stretch marks. It works by applying an array of gold-plated, tapered micro-diameter needles deep into the skin to precisely deliver radiofrequency energy. Since radiofrequency technology targets water instead of melanin, Intensif provides a safe & efficient option for fractional skin remodeling in people of all skin types—including those with darker skin, lighter/more sensitive skin, and even tanned skin in the summer months.

Intensif provides the only mechanized, shock-free needle insertion that physicians can completely control, including needle depth, allowing for 5 times deeper treatments than fractional lasers and 3 times faster treatments than other needle technologies available today. While older fractional remodeling technologies left scarring, redness, risk of hyperpigmentation, Intensif offers a fresh look at microneedling, targeting deeper layers of the skin (up to 3.5 MM) with little to no epidermal damage.

About EndyMed Medical

EndyMed Medical Ltd., established in 2007, offers energy based aesthetic treatment systems for the professional markets. EndyMed's proprietary 3DEEP® radiofrequency technology is a unique solution for fractional and non-ablative wrinkle treatment, skin tightening on both the face and body, body contouring and acne scar treatment. Through the three dimensional interaction of multiple RF sources, 3DEEP® RF creates deep thermal patterns in the tissue which is a novel and effective approach to aesthetic treatments. For more information, please see our website at http://www.endymed.com.

Tammy Weisman Maman, EndyMed Medical, Ltd., http://www.endymed.com, +972 577750036, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.